Patents by Inventor Johan Lindström

Johan Lindström has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11919902
    Abstract: The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula: wherein A, X, Y, Z, Q, R1, R2, R3, R4, R5, and n are described herein.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: March 5, 2024
    Assignee: HiberCell, Inc.
    Inventors: Johan Lindström, Lars Boukharta Persson, Madeleine Livendahl, Jenny Viklund, Tobias Ginman, Rickard Forsblom, Fredrik Rahm, Edward A. Kesicki, Kannan Karukurichi Ravi, Eugene R. Hickey, Markus K. Dahlgren, Aleksey I. Gerasyuto
  • Publication number: 20230322772
    Abstract: The invention provides novel azaindolylpyridone and diazaindolylpyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory diseases, autoimmune diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R2, R3 and X are as defined in the specification.
    Type: Application
    Filed: October 11, 2022
    Publication date: October 12, 2023
    Inventors: Johan Lindström, Rickard Forsblom, Fredrik Rahm, Jenny Viklund
  • Patent number: 11780858
    Abstract: The invention provides novel pyridinamine-pyridone and pyrimidinamine-pyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory disease, neurodegenerative disorders, cardiovascular disorders, autoimmune diseases and viral infections; wherein R1, R2, R3 and Z are as defined in the specification.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: October 10, 2023
    Assignee: Sprint Bioscience AB
    Inventors: Johan Lindström, Rickard Forsblom, Tobias Ginman, Fredrik Rahm, Jenny Viklund
  • Publication number: 20230234949
    Abstract: The invention provides novel morpholinylpyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory diseases, autoimmune diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R1, R2 and A are as defined in the specification.
    Type: Application
    Filed: December 19, 2022
    Publication date: July 27, 2023
    Inventors: Johan Lindström, Rickard Forsblom, Jenny Viklund
  • Patent number: 11677800
    Abstract: An electronic device, while providing a first playlist for playback by a media device, maintains a play queue for a first user that is initially populated with a list of media content items to be played by the media device, the initially populated list of media content items including media content items distinct from the first playlist and selected by the first user and media content items from the first playlist. The electronic device receives a request to change playback from the first playlist to a second playlist different from the first playlist. In response to the request to change the playback from the first playlist to the second playlist, the electronic device maintains, in the play queue, the media content items selected by the first user while changing playback from the first playlist to the second playlist.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: June 13, 2023
    Assignee: Spotify AB
    Inventors: Per Eckerdal, Johan Lindström, Emil Eriksson
  • Patent number: 11667651
    Abstract: The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula: where A, B, R1, X1, X2, and W are described herein.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: June 6, 2023
    Assignee: HiberCell, Inc.
    Inventors: Johan Lindström, Lars Boukharta Persson, Jenny Viklund, Edward A. Kesicki, Eugene R. Hickey, Markus K. Dahlgren, Aleksey I. Gerasyuto
  • Patent number: 11633403
    Abstract: The invention provides novel 6-aryl or 6-heteroaryl 4-morpholin-4-yl-pyhdine-2-one compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, diabetes, inflammatory diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R1, R2, R3 and R4 are as defined in the specification.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: April 25, 2023
    Assignee: Sprint Bioscience AB
    Inventors: Jessica Martinsson, Martin Andersson, Johan Lindström, Rickard Forsblom, Fredrik Rahm, Tobias Ginman, Jenny Viklund
  • Patent number: 11584763
    Abstract: The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula: where A1, A2, G, R1, R2, R3, R4, and W are described herein.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: February 21, 2023
    Assignee: HiberCell, Inc.
    Inventors: Johan Lindström, Lars Boukharta Persson, Jenny Viklund, Rickard Forsblom, Tobias Ginman, Edward A. Kesicki, Eugene R. Hickey, Markus K. Dahlgren, Aleksey I. Gerasyuto
  • Patent number: 11560374
    Abstract: The invention provides novel morpholinylpyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory diseases, autoimmune diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; Formula (I) wherein R1, R2 and A are as defined in the specification.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: January 24, 2023
    Assignee: Sprint Bioscience AB
    Inventors: Johan Lindström, Rickard Forsblom, Jenny Viklund
  • Patent number: 11535635
    Abstract: The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula: where A1, A2, G, R1, R2, R3, R4, and W are described herein.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: December 27, 2022
    Assignee: HiberCell, Inc.
    Inventors: Johan Lindström, Lars Boukharta Persson, Jenny Viklund, Rickard Forsblom, Tobias Ginman, Edward A. Kesicki, Eugene R. Hickey, Markus K. Dahlgren, Aleksey I. Gerasyuto
  • Publication number: 20220388495
    Abstract: The invention relates to a method, performed by a control device, for driving at least one power consumer connected to a powertrain of a vehicle. The at least one propulsion unit comprises a first electrical machine and a second electrical machine, wherein the first electrical machine is connected to a first main shaft and the second electrical machine is connected to a second main shaft. A connection shaft is connected to the first electrical machine; and the at least one power consumer comprises a first power consumer connected to the first main shaft and/or a second power consumer connected to the connection shaft.
    Type: Application
    Filed: October 27, 2020
    Publication date: December 8, 2022
    Inventors: Mathias Björkman, Niklas Pettersson, Fredrik Sundén, Mikael Bergquist, Johan Lindström
  • Patent number: 11498919
    Abstract: The invention provides novel azaindolylpyridone and diazaindolylpyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory diseases, autoimmune diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R2, R3 and X are as defined in the specification.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: November 15, 2022
    Assignee: Sprint Bioscience AB
    Inventors: Johan Lindström, Rickard Forsblom, Fredrik Rahm, Jenny Viklund
  • Publication number: 20220306178
    Abstract: According to a first aspect of the present disclosure, there is provided a dolly featuring at least one wheel, an auto-engaging brake, and a release mechanism for selectively manipulating the auto-engaging brake from an applied state to a released state. The dolly further includes a tow bar which is connected to the release mechanism for operating the auto-engaging brake between the applied and released state.
    Type: Application
    Filed: March 21, 2022
    Publication date: September 29, 2022
    Inventors: Jack Grönholm, Johan Lindström, Thomas Oriander, Jussi Raninen
  • Patent number: 11446997
    Abstract: A hybrid powertrain that includes a combustion engine (4) and a gearbox (2) with an input shaft (8) and an output shaft (20); a first planetary gear (10) connected to the input shaft (8); a second planetary gear (12) connected to the first planetary gear (10); a first electrical machine (14) connected to the first planetary gear (10); a second electrical machine (16) connected to the second planetary gear (12); at least one gear pair (G1, 60, 72) connected to the first planetary gear (10) and to the output shaft (20); and at least one gear pair (G2, 66, 78) connected to the second planetary gear (12) and to the output shaft (20), a countershaft (18) provided between the combustion engine (4) and the gearbox (2) so that the engine (4) can be disconnected from the gearbox (2). Also disclosed is a method for controlling the disclosed hybrid powertrain (3). Also a vehicle (1) includes such a gearbox (2), and a method to control such a gearbox (2). Also a computer program (P) to control a gearbox.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: September 20, 2022
    Assignee: Scania CV AB
    Inventors: Mathias Björkman, Niklas Pettersson, Johan Lindström, Mikael Bergquist
  • Publication number: 20220218688
    Abstract: The invention provides novel pyridylpyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory disease, autoimmune diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R1, R2, R3 and X are as defined in the specification.
    Type: Application
    Filed: December 15, 2021
    Publication date: July 14, 2022
    Inventors: Johan Lindström, Rickard Forsblom, Tobias Ginman, Fredrik Rahm, Jenny Viklund
  • Publication number: 20220175788
    Abstract: The invention provides novel 6-heterocyclyl-4-morpholin-4-yl-pyridine-2-one compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, diabetes, inflammatory disease, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R1, R2, R3 and A are as defined in the specification.
    Type: Application
    Filed: October 14, 2021
    Publication date: June 9, 2022
    Inventors: Jessica Martinsson, Martin Andersson, Johan Lindström, Rickard Forsblom, Fredrik Rahm, Tobias Ginman, Jenny Viklund
  • Publication number: 20220177495
    Abstract: The invention provides novel pyridinamine-pyridone and pyrimidinamine-pyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory disease, neurodegenerative disorders, cardiovascular disorders, autoimmune diseases and viral infections; wherein R1, R2, R3 and Z are as defined in the specification.
    Type: Application
    Filed: November 18, 2021
    Publication date: June 9, 2022
    Inventors: Johan Lindström, Rickard Forsblom, Tobias Ginman, Fredrik Rahm, Jenny Viklund
  • Publication number: 20220174106
    Abstract: An electronic device, while providing a first playlist for playback by a media device, maintains a play queue for a first user that is initially populated with a list of media content items to be played by the media device, the initially populated list of media content items including media content items distinct from the first playlist and selected by the first user and media content items from the first playlist. The electronic device receives a request to change playback from the first playlist to a second playlist different from the first playlist. In response to the request to change the playback from the first playlist to the second playlist, the electronic device maintains, in the play queue, the media content items selected by the first user while changing playback from the first playlist to the second playlist.
    Type: Application
    Filed: December 17, 2021
    Publication date: June 2, 2022
    Inventors: Per Eckerdal, Johan Lindström, Emil Eriksson
  • Publication number: 20220117974
    Abstract: The invention provides novel 6-aryl or 6-heteroaryl 4-morpholin-4-yl-pyhdine-2-one compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, diabetes, inflammatory diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R1, R2, R3 and R4 are as defined in the specification.
    Type: Application
    Filed: June 29, 2021
    Publication date: April 21, 2022
    Inventors: Jessica MARTINSSON, Martin ANDERSSON, Johan LINDSTRÖM, Rickard FORSBLOM, Fredrik RAHM, Tobias GINMAN, Jenny VIKLUND
  • Patent number: D1004897
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: November 14, 2023
    Assignee: K. HARTWALL OY AB
    Inventor: Johan Lindström